Similar to established BPH treatments like finasteride [30] and osaterone acetate [45], dogs with BPH that received oral tadalafil at 5 mg/day for 30 days showed a significant reduction in CPSE, PSA, and prostatic acid phosphatase serum levels [57]. Here, KLK3 is linked to benign prostatic hyperplasia.